The role of tumor board conferences in neuro-oncology: a nationwide provider survey James SnyderLonni SchultzTobias Walbert Topic Review 18 April 2017 Pages: 1 - 7
Can anti-vascular endothelial growth factor antibody reverse radiation necrosis? A preclinical investigation Chong DuanCarlos J. Perez-TorresJoel R. Garbow Laboratory Investigation 19 April 2017 Pages: 9 - 16
Incidence and survival trends in oligodendrogliomas and anaplastic oligodendrogliomas in the United States from 2000 to 2013: a CBTRUS Report Rebecca L. AcheyVishesh KhannaJill S. Barnholtz-Sloan Laboratory Investigation 10 April 2017 Pages: 17 - 25
Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data Maciej A. MazurowskiKal ClarkAshirbani Saha Laboratory Investigation 03 May 2017 Pages: 27 - 35
IDH mutation and 1p19q codeletion distinguish two radiological patterns of diffuse low-grade gliomas Amélie DarlixJérémy DeverdunHugues Duffau Laboratory Investigation 22 April 2017 Pages: 37 - 45
Expression and function of ABCG2 and XIAP in glioblastomas Ivette F. EmeryArchana GopalanKyuson Yun Laboratory Investigation 21 April 2017 Pages: 47 - 57
MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT Er NieXin JinYongping You Laboratory Investigation 19 April 2017 Pages: 59 - 68
Negative prognostic effect of low nuclear GLI1 expression in glioblastomas Yuil KimIn-Gu DoYeon-Lim Suh Laboratory Investigation 17 April 2017 Pages: 69 - 76
Flow arrest intra-arterial delivery of small TAT-decorated and neutral micelles to gliomas Juliane NguyenShaolie S. HossainShailendra Joshi Laboratory Investigation 18 April 2017 Pages: 77 - 85
CDC20 with malignant progression and poor prognosis of astrocytoma revealed by analysis on gene expression Yiming DingShuqing YuTingyu Liang Laboratory Investigation 21 April 2017 Pages: 87 - 95
Improving the utility of 1H-MRS for the differentiation of glioma recurrence from radiation necrosis Ian D. CrainPetra S. EliasMark C. Preul Clinical Study 29 May 2017 Pages: 97 - 105
Cerebrospinal fluid dissemination of high-grade gliomas following boron neutron capture therapy occurs more frequently in the small cell subtype of IDH1R132H mutation-negative glioblastoma Natsuko KondoRolf F. BarthNorman L. Lehman Clinical Study 22 May 2017 Pages: 107 - 118
Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach Taryn B. Fay-McClymontDanielle M. PloetzLucie Lafay-Cousin Clinical Study 12 April 2017 Pages: 119 - 128
Assessment of prognostic scores of brain metastases from lung adenocarcinoma with EGFR mutations Hongwei LiJianhong LianShengmin Lan Clinical Study 08 April 2017 Pages: 129 - 135
Does early resection of presumed low-grade glioma improve survival? A clinical perspective Maarten M. J. WijnengaTariq MattniArnaud J. P. E. Vincent Clinical Study Open access 11 April 2017 Pages: 137 - 146
Preoperative grading of supratentorial nonenhancing gliomas by high b-value diffusion-weighted 3 T magnetic resonance imaging Haiwei HanChengkun HanHua Wu Clinical Study 24 April 2017 Pages: 147 - 154
Biopsy targeting with dynamic contrast-enhanced versus standard neuronavigation MRI in glioma: a prospective double-blinded evaluation of selection benefits Vera C. KeilBogdan PinteaDariusch R. Hadizadeh Clinical Study 19 April 2017 Pages: 155 - 163
Single fraction spine stereotactic ablative body radiotherapy with volumetric modulated arc therapy Matthew M. GestautNitika ThawaniMehul Patel Clinical Study 13 April 2017 Pages: 165 - 172
Survival trends of oligodendroglial tumor patients and associated clinical practice patterns: a SEER-based analysis Michael G. BrandelAli A. AlattarClark C. Chen Clinical Study 24 April 2017 Pages: 173 - 181
Rapid progression to glioblastoma in a subset of IDH-mutated astrocytomas: a genome-wide analysis Timothy E. RichardsonMatija SnuderlKimmo J. Hatanpaa Clinical Study 18 April 2017 Pages: 183 - 192
Defining optimal cutoff value of MGMT promoter methylation by ROC analysis for clinical setting in glioblastoma patients Guoqiang YuanLiang NiuYawen Pan Clinical Study 17 May 2017 Pages: 193 - 201
Is there a potential role for EGFR expression to lead margin reduction in glioblastoma? Paolo TiniValerio NardoneLuigi Pirtoli Letter to the Editor 05 April 2017 Pages: 203 - 205
Primary cranial sarcomatoid carcinoma Nishanth SadashivaB. N. NandeeshBhagavatula Indira Devi Letter to the Editor 08 April 2017 Pages: 207 - 209
The growing role of biology in the treatment of glioblastoma: no more one kind of disease Michela BuglioneLuca TriggianiStefano Maria Magrini Letter to the Editor 20 April 2017 Pages: 211 - 212
ZEB1 expression in Chinese lower-grade gliomas Xiangyan HuangHarrison X. BaiLi Yang Letter to the Editor 18 April 2017 Pages: 213 - 215
Molecular alterations in pediatric gliomatosis cerebri are similar to those in less invasive forms of pediatric diffuse glioma Blandine BoisselierEmilie De CarliAudrey Rousseau Letter to the Editor 18 April 2017 Pages: 217 - 219
Erratum to: Rapid progression of intracranial melanoma metastases controlled with combined BRAF/MEK inhibition after discontinuation of therapy: a clinical challenge Daniel N. CagneyBrian M. AlexanderAyal A. Aizer Erratum 19 May 2017 Pages: 221 - 221
